Janus Henderson's Global Life Sciences portfolio returned 12.10% in Q2 2026, outperforming its benchmark. Read the full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results